3-month relief: Final call for 10,000 pharmacists to renew registration
At least 70,000 pharmacists are registered in Haryana; of these, about 10,000 — whose registrations expired on December 31, 2020, — have not yet renewed The Haryana State Pharmacy Council…
Marksans Pharma gets USFDA nod for generic Benzonatate capsules
Marksans Pharma Ltd on Wednesday said it has received final approval from the US health regulator for its generic version of Benzonatate capsules indicated for treatment of persistent cough, bronchitis,…
Greatest Defender of Consumer Rights doesn’t like Sound of Patient as ‘GRAHAK’
Must be Music to Ears of Doctors’ Community, desperate to be out of Consumer Protection Act New Delhi: In Constitution Club, it was the occasion of official launch of best…
Roche launches the cobas MPX-E assay, a new 4-in-1 donor screening test
Basel- Roche announced today that the cobas® MPX-E assay, a qualitative in-vitro test for the detection and discrimination of Human Immunodeficiency Virus (HIV 1 and 2) and Hepatitis C, B,…
Haryana Mandates Real-Time Medicine Tracking In Govt Hospitals
Chandigarh: In a major push to strengthen public healthcare, the Haryana Government has directed all government hospitals to maintain medicine stock records on a real-time centralised portal, ensuring transparency and…
Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices
New Delhi: The Parliamentary Panel on Health and Family Welfare has recommended various significant regulatory changes in the regulation of medical devices, including decentralisation of approval for all medical devices…
Diabetic drug metformin found to act on brain
NEW DELHI: Cheap, effective and widely trusted, metformin has long been the first choice for treating type 2 diabetes. Now, scientists say the drug works in a way few had…
Hetero debuts semaglutide generic in emerging markets
New Delhi: Hyderabad-based drugmaker Hetero has announced the launch of its generic semaglutide portfolio in emerging international markets. In a phased global push, the company plans to roll out its…
LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial
Phase 2 results for LB-102 showed statistically significant reductions in PANSS total score across all doses with onset by week 1 and sustained through study end, alongside low rates of…
Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority
After substandard drug manufacturing, the state drug firms are once again under the scanner of the central government for manufacture and sale of unapproved fixed dose combination (FDC) drugs which…
